Skip to main content
. 2017 Oct 31;8(63):106206–106221. doi: 10.18632/oncotarget.22175

Figure 3. Correlations between serum CgA levels and anti-EID3 Ab levels in NF-pNET patients.

Figure 3

(A) Scatter dot blots of serum CgA levels tested with sera from 25 NF-pNET patients and 25 HDs. There was no significant difference in serum CgA levels between the two groups. (B) Correlation analysis of serum CgA and anti-EID3 Ab levels in patient group (n = 25). The serum levels of anti-EID3 Abs correlate with serum CgA levels. (r = 0.411, p = 0.041, Pearson’s correlation). CgA: Chromogranin A, NF-pNET: non-functional pancreas neuroendocrine tumor.